AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2016

Jun 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2016-06-21

Reporting Person: Foster-Cheek Kaye I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-21	Stock option (right to buy)	$47.33	A	9000	Acquired	2026-06-20	Common stock (9000)	Direct

Footnotes

F1: This option was granted on June 21, 2016. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2017.